Fig. 7From: Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell linesTrajectories of MKN1 cells treated with trastuzumab or afatinib. MKN1 cells were treated with 5âÎŒg/ml trastuzumab (Tra), 0.5âÎŒM afatinib (Afa), 5âÎŒg/ml trastuzumab +â0.5âÎŒM afatinib (Traâ+âAfa) or afatinib solvent DMSO (0.05%). Untreated (untr) cells were used as control. Cell movement was tracked for 7âh to assess approximate average speed. The trajectories of one exemplary film for each condition are shown. The trajectories were color-coded for approximate average speedBack to article page